MedKoo Cat#: 208213 | Name: RIPK2 Protac 20

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RIPK2 Protac 20 possessed the best overall profile with good solubility, potent degradation of RIPK2, and associated inhibition of TNFα release. RIPK2 Protac 20 recruits members of the inhibitor of apoptosis (IAP) family of E3 ligases. This represents an attractive alternative dosing paradigm to oral delivery, especially for chronic diseases where compliance can be challenging.

Chemical Structure

RIPK2 Protac 20
RIPK2 Protac 20
CAS#unknown

Theoretical Analysis

MedKoo Cat#: 208213

Name: RIPK2 Protac 20

CAS#: unknown

Chemical Formula: C50H66F2N14O7S

Exact Mass: 1044.4928

Molecular Weight: 1045.23

Elemental Analysis: C, 57.46; H, 6.36; F, 3.64; N, 18.76; O, 10.71; S, 3.07

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
RIPK2Protac20, RIPK2Protac-20, RIPK2-Protac20
IUPAC/Chemical Name
5-(4-(3-((6-(tert-Butylsulfonyl)-4-((4,5-dimethyl-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)piperazin-1-yl)-N-((3S,5S)-5-((2,6-difluorophenyl)carbamoyl)-1-((R)-3,3-dimethyl-2-((R)-2-(methylamino)propanamido)butanoyl)pyrrolidin-3-yl)pyrazine-2-carboxamide
InChi Key
HOCBQAJEQVABHZ-VELKCZJJSA-N
InChi Code
InChI=1S/C50H66F2N14O7S/c1-28(2)74(71,72)41-21-33-36(57-27-58-46(33)61-45-29(3)30(4)62-63-45)22-40(41)73-19-11-14-64-15-17-65(18-16-64)42-25-54-37(23-55-42)48(69)59-32-20-38(39(67)24-56-43-34(51)12-10-13-35(43)52)66(26-32)49(70)44(50(6,7)8)60-47(68)31(5)53-9/h10,12-13,21-23,25,27-28,31-32,38,44,53,56H,11,14-20,24,26H2,1-9H3,(H,59,69)(H,60,68)(H2,57,58,61,62,63)/t31-,32+,38-,44+/m1/s1
SMILES Code
FC1=C(NCC([C@H]2C[C@H](NC(C3=NC=C(N4CCN(CCCOC5=CC6=NC=NC(NC7=NNC(C)=C7C)=C6C=C5S(=O)(C(C)C)=O)CC4)N=C3)=O)CN2C([C@H](NC([C@@H](C)NC)=O)C(C)(C)C)=O)=O)C(F)=CC=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,045.23 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Miah AH, Smith IED, Rackham M, Mares A, Thawani AR, Nagilla R, Haile PA, Votta BJ, Gordon LJ, Watt G, Denyer J, Fisher DT, Dace P, Giffen P, Goncalves A, Churcher I, Scott-Stevens P, Harling JD. Optimization of a Series of RIPK2 PROTACs. J Med Chem. 2021 Sep 9;64(17):12978-13003. doi: 10.1021/acs.jmedchem.1c01118. Epub 2021 Aug 25. PMID: 34432979.